Financial

Acesion Pharma Strengthens Clinical Team With Key Appointments

Appoints experienced Chief Medical Officer and Director Clinical Operations COPENHAGEN, Denmark, May 5, 2020 /PRNewswire/ — Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recruited Anders Gaarsdal Holst as its Chief Medical Officer (CMO) to succeed Nils Edvardsson, who […]

Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market

HANGZHOU, China and ATLANTA, May 2, 2020 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (“Venus Medtech” or the “Company”, together with its subsidiaries, the “Group”, stock code: 2500), the leading Chinese transcatheter heart valve company and Opus Medical Therapies, LLC, a medical device company focused on developing transcatheter mitral and tricuspid valve replacement products for patients undergoing […]

Sequana Medical Announces the Appointment of Dr. Oliver Gödje as Chief Medical Officer

GHENT, Belgium, May 04, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointment of Oliver Gödje, MD, PhD, as Chief Medical Officer, with immediate effect. Dr Gödje replaces Gijs Klarenbeek, MD, […]

CryoLife Reports First Quarter 2020 Financial Results

ATLANTA, April 30, 2020 /PRNewswire/ — First Quarter and Recent Business Highlights: Achieved total revenues of $66.4 million in the first quarter 2020 versus preliminary first quarter 2020 revenues of $65.5 million Total revenues decreased 2% and decreased 1% on a constant currency basis versus first quarter 2019 Excluding TMR, total revenues increased 1% and […]

Abiomed Announces Q4 FY 2020 Revenue of $207 Million and 28.1% Operating Margin

FY 2020 Annual Revenue of $841 Million, Up 9%, and 29.6% Operating Margin DANVERS, Mass.–(BUSINESS WIRE)–Apr. 30, 2020– Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported fourth quarter fiscal 2020 revenue of $206.7 million compared to revenue of $207.1 million for the same period of fiscal 2019. For fiscal year 2020, […]